Presentations

Oct 4

Stemina Presented at the Annual Meeting of the Northland Chapter of SOT

Oct 4, 2017
Developmental Toxicity Potency of Valproate Analogues in a Human Pluripotent Stem Cell-Based Assay Presented at the Annual Meeting of the Northland Chapter of the Society of Toxicology (September 2017) by Jessica Palmer, Associate Director of Toxicology Development and validation of alternative models for developmental toxicity testing is essential for reducing the number of animals used

Read more
Aug 16

Utilizing devTOXqP in a Combined Testing Approach for Identifying Developmental Toxicity Liability of Chemicals [Webinar Slides]

Aug 16, 2017
Why develop devTOX? Reduce prevalence of birth defects and decrease animal testing. Our approach represents a unique opportunity to screen compound safety using a human endpoint. devTOX quickPredict is a predictive, targeted biomarker assay. (devTOX Discovery, on the other hand, is a predictive, untargeted metabolomics assay.) Jessica Palmer presented this webinar in October 2016. If

Read more
Jun 26

Presentation slides: Stemina participates in platform session at Teratology Society Annual Meeting

Jun 26, 2017
Presented at the Teratology Society’s 57th Annual Meeting in Denver, Colorado in June 2017 by Stemina’s Associate Director of Toxicology, Jessica Palmer. Previous approaches for evaluating the accuracy of alternative test methods have been based on the classification of a chemical as either a positive or negative, with no other distinction. This method does not

Read more
Jun 14

Stemina’s Jessica Palmer to Present at Teratology Society Annual Meeting

Jun 14, 2017
Jessica Palmer, Stemina’s Associate Director of Toxicology, will present at the Teratology Society’s 57th Annual Meeting, held June 24-28, 2017 in Denver. Anyone interested in developmental toxicity assays is encouraged to attend. Prediction of Developmental Toxicity Potential by In Vivo Exposures with a Biomarker-Based Human Pluripotent Stem Cell Assay This presentation is part of Platform

Read more
Feb 20

Stemina to Present Sponsored Session, Poster at SOT’s Annual Meeting & ToxExpo 2017

Feb 20, 2017
Stemina Biomarker Discovery will be well represented at the Society of Toxicology’s 56th Annual Meeting and ToxExpo. In addition to participating in SOT as an exhibitor (booth 2506), Stemina’s Jessica Palmer, Associate Director of Toxicology, will present new research in two sessions: Poster session: Monday, March 13th | 9:30 AM – 12:45 PM | P331

Read more
Jan 18

Stemina Hosts Webinar: Exposure-Based Developmental Toxicity Prediction with the devTOX quickPredict Assay

Jan 18, 2017
The required in vivo preclinical models for developmental toxicity testing have varying degrees of concordance with human effects, having approximately 70% concordance to known human developmental toxins. Development and validation of alternative methods for assessing developmental toxicity potential, such as the devTOX quickPredict assay (devTOXqP) would decrease the time, expense, and use of vertebrate animals.

Read more
Apr 11

Stemina Hosts Session at SOT 2016

Apr 11, 2016
Follow the link to view the presentation from Stemina’s session at SOT: Practical Application of a Human Stem Cell Assay for Developmental Toxicity Testing

Read more
Jun 8

Laura Egnash Speaks at ASMS Agilent Users Meeting

Jun 8, 2013
Laura Egnash was invited to speak at the Agilent Users’ Meeting in Minneapolis on June 8, 2013 at the American Society of Mass Spectrometry annual conference. Follow the link at right to view her full presentation, “Applying Metabolomics for Novel Biomarker Discovery and Commercial Assay Development.”

Read more
May 29

Stemina Hosts Session at SOT 2013

May 29, 2013
Stemina’s CEO, Beth Donley, presented Stemina’s new in vitro assay for prediction of developmental toxicity: devTOX quickPredict.

Read more
May 22

Dr. Paul West Speaks at ASMS Agilent Users Meeting

May 22, 2010
Paul West was invited to speak at the Agilent Users Meeting in Salt Lake City on May 22, 2010 at the American Society of Mass Spectrometry annual meeting. Follow the link at right to view his full presentation, “Discovering Biomarkers of Human Disease and Development Using Stem Cells and Metabolomics.”

Read more
Sep 23

Dr. Paul West Presents Webinar

Sep 23, 2009
Paul West was invited to present at a Genetic Engineering News & Biotechnology Webinar, “Advances in Compound Identification Using Metabolomics”. The primary focus of Dr. West’s presentation entitled “De Novo Metabolite Chemical Structure Determination” is metabolite chemical structure determination using LC-MS, accurate mass and MS-MS. The Webinar was presented on September 23, 2009.

Read more